Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. We report a 55-year-old female with seropositive rheumatoid arthritis for 10 years who developed large mediastinal and hilar adenopathy while receiving etanercept therapy. Chest high resolution computed tomography (HRCT) showed mediastinal lymph nodes with size of 2.3 × 3.1 centimeters. Right paratracheal lymph node biopsy showed nonnecrotizing epithelioid granulomata. All infectious studies of pulmonary lymph node tissues were negative. Etanercept was discontinued. Follow-up HRCT 6 months later showed resolution of mediastinal lymph nodes.This report should increase awareness of pulmonary sarcoido...
Contains fulltext : 52030.pdf (publisher's version ) (Closed access)OBJECTIVE: Alt...
International audienceAnti-TNF-alpha agents have been tried in cases of refractory sarcoidosis, givi...
peer reviewedOver recent years, anti-TNFalpha have been used to treat rheumatoid arthritis. The prin...
We report a 55-year-old female with seropositive rheumatoid arthritis for 10 years who developed lar...
Etanercept is a soluble receptor fusion protein that inhibits tumor necrosis factor-alpha(TNF-&alpha...
International audienceINTRODUCTION: TNF blockers are widely used to treat inflammatory rheumatic dis...
Etanercept is a soluble receptor fusion protein that inhibits tumor necrosis factor-alpha(TNF-&alpha...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Sarcoidosis is a systemic chronic granulomatous disease of unknown etiology. It predominantly involv...
Summary We report the case of a patient with rheumatoid arthritis who, after 2 months of treatment w...
Adalimumab is a full human monoclonal antibody that inhibits tumor necrosis factor-alpha (TNF-${\alp...
Drug-induced sarcoidosis-like disease is a rare side effect of anti-tumor necrosis factor (anti-TNF)...
Adalimumab is a full human monoclonal antibody that inhibits tumor necrosis factor-alpha (TNF-&alpha...
International audienceOBJECTIVE: TNF blockers have been recently evaluated for treating refractory s...
Objectives: to report 2 cases of sarcoidosis developed during treatment with anti-TNFalfa antagonist...
Contains fulltext : 52030.pdf (publisher's version ) (Closed access)OBJECTIVE: Alt...
International audienceAnti-TNF-alpha agents have been tried in cases of refractory sarcoidosis, givi...
peer reviewedOver recent years, anti-TNFalpha have been used to treat rheumatoid arthritis. The prin...
We report a 55-year-old female with seropositive rheumatoid arthritis for 10 years who developed lar...
Etanercept is a soluble receptor fusion protein that inhibits tumor necrosis factor-alpha(TNF-&alpha...
International audienceINTRODUCTION: TNF blockers are widely used to treat inflammatory rheumatic dis...
Etanercept is a soluble receptor fusion protein that inhibits tumor necrosis factor-alpha(TNF-&alpha...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Sarcoidosis is a systemic chronic granulomatous disease of unknown etiology. It predominantly involv...
Summary We report the case of a patient with rheumatoid arthritis who, after 2 months of treatment w...
Adalimumab is a full human monoclonal antibody that inhibits tumor necrosis factor-alpha (TNF-${\alp...
Drug-induced sarcoidosis-like disease is a rare side effect of anti-tumor necrosis factor (anti-TNF)...
Adalimumab is a full human monoclonal antibody that inhibits tumor necrosis factor-alpha (TNF-&alpha...
International audienceOBJECTIVE: TNF blockers have been recently evaluated for treating refractory s...
Objectives: to report 2 cases of sarcoidosis developed during treatment with anti-TNFalfa antagonist...
Contains fulltext : 52030.pdf (publisher's version ) (Closed access)OBJECTIVE: Alt...
International audienceAnti-TNF-alpha agents have been tried in cases of refractory sarcoidosis, givi...
peer reviewedOver recent years, anti-TNFalpha have been used to treat rheumatoid arthritis. The prin...